EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, Maria G, Andreoli, Laura, Limper, Marteen, Amoura, Zahir, Cervera, Ricard, Costedoat-Chalumeau, Nathalie, Cuadrado, Maria Jose, Dörner, Thomas +16 more·2019·Annals of the Rheumatic Diseases
DOI 10.1136/annrheumdis-2019-215213

Cited by (1,254)

Items 501–600 of 1,254

  1. Three cases of systemic lupus erythematosus presenting with ischemic stroke as the initial symptom: Case reports and literature review
    Na Li, Xiaoxia Liu, Pengjia Wu · 2024 · Immunity Inflammation and Disease
  2. Proteomics analysis of plasm exosomes in early pregnancy among normal pregnant women and those with antiphospholipid syndrome
    Yeli Sun, Zheng Wang, Junyuan Li · 2024 · Heliyon
  3. Establishment of ELISA-comparable moderate and high thresholds for anticardiolipin and anti-β2 glycoprotein I chemiluminescent immunoassays according to the 2023 ACR/EULAR APS classification criteria and evaluation of their diagnostic performance
    Polona Žigon, Nika Boštic, Aleš Ambrožič, Žiga Rotar, Elizabeta Blokar, Manca Ogrič, Saša Čučnik · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
  4. Development of a risk prediction model for the first occurrence of thrombosis in patients with OAPS
    Jie Gao, Yan Zheng, Zhuo Wang, Junfeng Jia, Jian Wan, Qing Han, Xi Zheng, Renli Liu, Zhaohui Zheng, Kaichun Wu et al. · 2024 · Frontiers in Immunology
  5. Complex Interaction between Gut Microbiome and Autoimmunity: Focus on Antiphospholipid Syndrome
    Olalekan Chris Akinsulie, Babatunde Ibrahim Olowu, Ridwan Olamilekan Adesola et al. · 2024 · Bacteria
  6. Thrombophilia Testing in Venous Thromboembolism
    Kristina Vrotniakaite-Bajerciene, Anne Angelillo‐Scherrer, Lana A. Castellucci · 2025 · Medical Clinics of North America
  7. Use of direct oral anticoagulants in antiphospholipid syndrome: Reply
    Hannah Cohen, Maria Efthymiou, David Alan Isenberg · 2020 · Journal of Thrombosis and Haemostasis
  8. Treatment of Systemic Lupus Erythematosus
    Bo Young Kim, Sung-Soo Kim · 2020 · Korean Journal of Medicine
  9. Distinct features of youth-onset primary antiphospholipid syndrome
    Carla Baleeiro, Camila SC Duran, Flávio Signorelli, Gustavo Guimarães Moreira Balbi, Eloísa Bonfá, Danieli C. O. Andrade · 2021 · Lupus
  10. Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
    Danielle Groat, Karlyn A. Martin, Rachel Pam Greenerger Rosovsky, Kristen Marie Sanfilippo, Manila Gaddh, Lisa Baumann Kreuziger, M. Elaine Eyster, Scott C. Woller · 2022 · Research and Practice in Thrombosis and Haemostasis
  11. Apport de la détection des anticorps antiphosphatidylsérine/prothrombine (aPS/PT) dans le diagnostic et la prise en charge du syndrome des antiphospholipides (SAPL)
    A Delarue, Marie‐Agnès Dragon‐Durey, Luc Darnige · 2022 · La Revue de Médecine Interne
  12. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
    Zara Sayar, Shoshana Burke, Prabal Mittal, Hannah Cohen · 2022 · Lupus
  13. Comparison of Point-of-Care PT-INR by Hand-Held Device with Conventional PT-INR Testing in Anti-phospholipid Antibody Syndrome Patients on Oral Anticoagulation
    Arvind Ganapati, John Mathew, Bijesh Yadav · 2022 · Indian Journal of Hematology and Blood Transfusion
  14. Seronegative Obstetric Antiphospholipid Syndrome Finally Treated Successfully
    Khawla K. Alghanim, Hezab A Alrayes, Rayan Mansour Aljurbua · 2022 · European Journal of Case Reports in Internal Medicine
  15. Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome
    Thomas Ballul, Arthur Mageau, Pascale Roland Nicaise · 2023 · Thrombosis Research
  16. Controversies in the Management of Antiphospholipid Syndrome
    Sabrina Porta, DANIELI CASTRO OLIVEIRA DE ANDRADE, Doruk Erkan, José Alfredo Gómez-Puerta, Luis Javier Jara, Paula Alba Moreyra, Guillermo Pons‐Estel · 2023 · JCR Journal of Clinical Rheumatology
  17. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years
    Antonella Tufano, Benjamin Brenner · 2023 · Seminars in Thrombosis and Hemostasis
  18. Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome
    George C Drosos, George D. Konstantonis, Petros Paul Sfikakis · 2023 · RMD Open
  19. Antiphospholipid syndrome in cardiovascular disease and cancer
    Ilias Pessach, Elias S. Kyriakou, Emmanouil Kalampokas, Theodoros Kalampokas, Aikaterini Bitsani, Ιoannis Kotsianidis · 2023 · European Journal Of Haematology
  20. Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program
    Anne E. Tebo, Willis Rohan, Ann Nwosu, Christine P. Bashleben, David A. Fox, Michael Andrew Linden, William J. Karlon · 2023 · Archives of Pathology & Laboratory Medicine
  21. Risks Following Total Knee Arthroplasty in Patients Who Have Antiphospholipid Syndrome
    Zhichang Zhang, Jialun A. Chi, Ian M. Duensing · 2023 · The Journal of Arthroplasty
  22. Vessel wall imaging in the diagnosis of antiphospholipid syndrome presenting as Moyamoya syndrome—A case report
    David L. Yang, Rachel Thomas, Alice Flynn Ford · 2024 · The Neuroradiology Journal
  23. Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation
    Maksymilian Hanarz, Michał Ząbczyk, Joanna Natorska · 2024 · Journal of Thrombosis and Haemostasis
  24. Precision medicine and the antiphospholipid syndrome: what is the future?
    Ignasi Rodríguez‐Pintó, Gerard Espinosa, Ricard Cervera · 2020 · Clinical Rheumatology
  25. Direct-acting oral anticoagulants in antiphospholipid syndrome
    Tatiana Magomedalievna Reshetnyak, Kamila S. Nurbaeva · 2021 · Rheumatology Science and Practice
  26. Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus
    Anna Viola Taulaigo, Liala Moschetti, Sara Ganhão, Maria Chiara Gerardi, Franco Franceschini, Anǵela Tincani, Laura Andréoli · 2021 · Expert Opinion on Drug Safety
  27. Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome
    Xiaojuan Zou, Zhongqi Fan, Ling Zhao · 2021 · BMC Gastroenterology
  28. Coexistent antiphospholipid syndrome and myeloproliferative neoplasm
    Zara Sayar, Susanna Nallamilli, Maria Efthymiou · 2021 · Lupus
  29. Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity
    Florence Assan, Laure Bottin, Camille Francès · 2021 · Annales de Dermatologie et de Vénéréologie
  30. Management of Pregnancy in Rheumatic Disease
    Sinead Maguire, Finbar D. O'Shea · 2021 · EMJ Rheumatology
  31. Antiphospholipid Syndrome
    Molly M. Daughety, Doruk Erkan, Michael D. Lockshin, Thomas L. Ortel · 2023 · Elsevier eBooks
  32. Thrombosis of Chiari’s network in the setting of non-bacterial thrombotic endocarditis occurring under non-vitamin K antagonist oral anticoagulation: a case report
    Wael Zaher, Amandine Balland, Michaël De Cubber · 2023 · European Heart Journal - Case Reports
  33. Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort study
    Haoyu Pan, Zetao Ding, Zhi‐Xia Yang, Zihan Tang, Lei Li, Jialin Teng, Yue Sun, Honglei Liu, Xiaobing Cheng, Yutong Su et al. · 2023 · Clinical Immunology
  34. Lupus und Thrombophilie
    Marie Lettau, Eva Vanessa Schrezenmeier, Christof Specker, Thomas Dörner · 2020 · Zeitschrift für Rheumatologie
  35. Antiphospholipid Syndrome
    Rohini Handa · 2021 · Clinical Rheumatology
  36. Clinical Characteristics and Prognosis of Patients With Antiphospholipid Antibodies Based on Cluster Analysis: An 8-Year Cohort Study
    Wanting Qi, Jiuliang Zhao, Can Liang Huang, Nan Jiang, Jing Li, Chanyuan Wu, Shangzhu Zhang, Chaojun Hu, Dong Zhu Xu, Qian Wang et al. · 2021 · Research Square
  37. Knowledge, attitudes, and practices of patients with lower limb fractures post-surgery regarding deep vein thrombosis
    Xiongwei Deng, Qiang Li, Meizhi Weng · 2025 · Scientific Reports
  38. A global survey on practice changes and barriers to the use of direct oral anticoagulants in children
    Laura Avila, Erica Di Ruggiero, Jennifer Vincelli, Leonardo Rodrigues Brandão · 2025 · Blood Advances
  39. Infection-Triggered Antiphospholipid Syndrome: A Critical Overview
    Svitlana Smiyan, Ganna Kuzmina, Olena Garmish · 2025 · Open Access Rheumatology Research and Reviews
  40. The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus
    Md Yuzaiful Md Yusof, Eve M D Smith, Hanna Lythgoe, Antonios Psarras, Kate Armon, Michael William Beresford, Lindsey S. Cherry, Christopher John Edwards, Lambert Felix, Kalveer Flora et al. · 2026 · Rheumatology
  41. Should bleeding be a concern in antiphospholipid syndrome?
    Fernanda Andrade Orsi · 2024 · Research and Practice in Thrombosis and Haemostasis
  42. Impact of Inherited Thrombophilia in Women with Obstetric Antiphospholipid Syndrome: A Single-Center Study and Literature Review
    Blanca Camacho Sáez, Víctor Manuel Martínez-Taboada, Ana Merino, Alejandra Comins‐Boo, Belén González-Mesones, Sara Del Barrio-Longarela, Leyre Riancho‐Zarrabeitia, Marcos López‐Hoyos, José L. Hernández · 2024 · Biomedicines
  43. Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?
    Víctor Manuel Martínez-Taboada, Ana Micieces Gómez, Ana Merino, Marcos López‐Hoyos, Sara Del Barrio-Longarela, Alejandra Comins‐Boo, Rafael Galvez, José L. Hernández · 2024 · Autoimmunity Reviews
  44. Impact of heparin‐aspirin therapy in patients with recurrent pregnancy loss characterized by thrombophilia resistant to low‐dose aspirin therapy: A retrospective study
    Tomoko Ichikawa, Takami Watanabe, Yumene Kubota, Shigeru Matsuda, Daisuke Shigemi, Sayuri Kasano, Ryoko Yokote, Mirei Yonezawa, Nozomi Ouchi, Yasuyuki Negishi et al. · 2025 · Reproductive Medicine and Biology
  45. Direct oral anticoagulant failure in patients with venous thromboembolism—why and what next?
    Dawn Swan, Robert Turner, Erik Lerkevang Grove, Sam Schulman, Jecko V. Thachil · 2025 · Journal of Thrombosis and Haemostasis
  46. Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case series
    Liling Zhou, Yong You, Shaozhe Cai, Cong Ye, Lingli Dong · 2025 · Clinical Rheumatology
  47. Cardiac Surgery in a Patient With Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia
    Eric R. Simon, Milap V. Rakholia, Marie LaPenta McHenry · 2021 · Journal of Cardiothoracic and Vascular Anesthesia
  48. Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism
    Vickie Kwan, Eric Kaplovitch, Rita Selby, Jameel Abdulrehman · 2021 · Journal of Thrombosis and Thrombolysis
  49. Exploring the risk factors and prognosis of transverse myelitis in systemic lupus erythematosus
    Minhui Wang, Ziqian Wang, Li Zhang et al. · 2022 · Therapeutic Advances in Chronic Disease
  50. Az autoantitest-vizsgálatok jelentősége szisztémás lupus erythematosusban
    Katalin T. Kovács, Gabriella Nagy, Bernadett Halda-Kiss, Gabór Kumánovics · 2022 · Orvosi Hetilap
  51. Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion
    José L. Hernández, José Javier Napal, Miguel Icardo, Paula González Bores, Rocío Pérez‐Montes, Andrea Cerveró, Zaida Salmón, José Manuel Olmos, Víctor Manuel Martínez-Taboada · 2022 · Thrombosis Research
  52. The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas
    Maja Gajić, Bianca Schröder‐Heurich, Monika Horvat Merčnik · 2023 · International Journal of Molecular Sciences
  53. Therapeutic changes of systemic lupus erythematosus (SLE) patients in pregnancy and feto-maternal outcomes: a retrospective cohort study
    Naser A. Al-Husban, Diala Walid Abu-Hassan, Ro’ya Ali Abu Saleem · 2024 · Journal of International Medical Research
  54. D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention
    Diona Gjermeni, Viktoria Anfang, Sofia Szabó, H Vetter, Ana C Venhoff, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Martin Buechsel, Dirk Westermann et al. · 2024 · Thrombosis Journal
  55. Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial
    Prabal Mittal, Rafael Gafoor, Zara Sayar, Maria Efthymiou, Ibrahim Tohidi‐Esfahani, Stella Appiah-Cubi, Deepa J. Arachchillage, David Atkinson, Ekaterina Bordea, M. Jorge Cardoso et al. · 2024 · Research and Practice in Thrombosis and Haemostasis
  56. A qualitative investigation of the experiences of patients living with antiphospholipid antibodies
    Francesca S. Cardwell, Alexandra O. Kobza, Susan J. Elliott, Paul Gibson, Nancy Soliman, Leslie Skeith, Ann Elaine Clarke, Megan R.W. Barber · 2024 · Lupus
  57. Examining postpartum anticoagulation practices: An international survey of healthcare providers
    Evangelia Vlachodimitropoulou, Marc Carrier, Kinga Malinowski, Adam C. Cuker, Eric Kaplovitch, Nadine Shehata · 2024 · Thrombosis Research
  58. Mort fœtale : consensus formalisé d’experts du Collège national des gynécologues et obstétriciens français
    Charles Garabédian, Jeanne Sibiude, Olivia Anselem, Tania Attié‐Bitach, Charline Bertholdt, Julie Blanc, Matthieu Dap, Isabelle de Mézerac, Catherine Fischer, Aude Girault et al. · 2024 · Gynécologie Obstétrique Fertilité & Sénologie
  59. Thrombotic antiphospholipid syndrome: From guidelines to clinical management
    D. Paredes, Daniel Martín‐Iglesias, Guillermo Ruiz‐Irastorza · 2024 · Medicina Clínica
  60. Unresolved issues in the diagnosis and management of thrombotic antiphospholipid syndrome
    Deepa J. Arachchillage, Michael Laffan · 2025 · Research and Practice in Thrombosis and Haemostasis
  61. Risk stratification and subgroup analysis of systemic lupus erythematosus patients with pregnancy: based on a 13-year multicenter cohort study
    Lingshan Liu, Can Huang, Hongbin Li et al. · 2025 · Clinical Rheumatology
  62. Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
    Denis G. Wahl, Virginie Dufrost · 2019 · Annals of Internal Medicine
  63. Schwangerschaft bei Lupus erythematodes – ein Update
    Rebecca Fischer‐Betz, Isabell Haase · 2020 · Zeitschrift für Rheumatologie
  64. ANTIPHOSPHOLIPID AND ANTINEUTROPHIL ANTIBODIES LEVELS IN MEN WITH STABLE CORONARY HEART DISEASE AND POSTINFARCTION CARDIOSCLEROSIS AND ITS RELATIONSHIP WITH THE DISEASE MANIFESTATION
    M. S. Nazarova, Mykola Stanislavchuk, L. V. Burdeina · 2020 · Wiadomości Lekarskie
  65. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis
    Shigeto Horita, Takeshi Zoshima, Satoshi Hara · 2021 · CEN Case Reports
  66. On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome – A systematic review and meta-analysis
    Tariq A. Lalmahomed, Isabel Johanna Walter, Anne Titia Lely · 2021 · Autoimmunity Reviews
  67. Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy
    Emanuela Sant’Antonio, Oscar Borsani, Chiara Camerini, Cirino Botta, Marco Santoro, Alessandro Allegra, Sergio Mario Siragusa · 2021 · Blood Reviews
  68. Anesthetic Management Using Epidural Analgesia for Emergency Laparoscopic Cholecystectomy in a Patient with Lupus Anticoagulant Positivity and Prolonged Activated Partial Thromboplastin Time
    Yasuhiro Watanabe, Toru Kaneda · 2022 · Case Reports in Anesthesiology
  69. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic
    Rita Selby, Jameel Abdulrehman · 2021 · The Journal of Applied Laboratory Medicine
  70. Response to: ‘Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’’ by Gao and Qin
    Maria G. Tektonidou, Anǵela Tincani, Michael M. Ward · 2021 · Annals of the Rheumatic Diseases
  71. Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis
    Alice Lipari, Silvia Sorrentino, Carlo Tamburini · 2023 · Internal and Emergency Medicine
  72. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity
    Pınar Akyüz Dağlı, Abdülsamet Erden, Hakan Babaoğlu · 2023 · Irish Journal of Medical Science (1971 -)
  73. Can transcriptomics guide the management of SLE-associated APS?
    Jason S. Knight, Maria G. Tektonidou · 2024 · Nature Reviews Rheumatology
  74. Exploring the Complexities of Non-Bacterial Thrombotic Endocarditis: Highlights from Literature and Case Studies
    Giuseppe Santarpino, Francesca Lofrumento, Concetta Zito et al. · 2024 · Journal of Clinical Medicine
  75. Поражение почек на фоне антифосфолипидного синдрома
    I.Yu. Golovach, Ye.D. Yehudіna, Д. Г. Рекалов · 2019 · KIDNEYS
  76. İnme klinik pratiğinde NOAK kullanımı: Türk Beyin Damar Hastalıkları Derneği Uzman Görüşü
    Bilgehan Atılgan Acar, Çetin Kürşad Akpınar, Zekeriya Alioğlu, Zülfikar Arlıer, Ethem Murat Arsava, Emrah Aytaç, Demet Funda Baş, Recep Baydemir, Murat Çabalar, Mehmet Uğur Çevik et al. · 2020 · Turkish Journal of Cerebrovascular Diseases
  77. Anti-PD-L1 monoclonal antibody for the management of chronic disseminated intravascular coagulation secondary to a urothelial carcinoma: a case report
    Silvia Maiorano, Wiebke Gulden‐Sala, Bernhard Gerber · 2022 · Journal of Medical Case Reports
  78. Heparin induced thrombocytopenia in pregnancy: A therapeutic challenge case report and literature review
    Seyyed Mojtaba Nekooghadam, Sepehr Ebrahimi‐Dehkordi, Elham Paraandavaji · 2023 · Clinical Case Reports
  79. Response to: 'Correspondence on 'EULAR recommendations for the management of antiphospholipid syndrome in adults' by Zhou et al
    Maria G. Tektonidou, Anǵela Tincani, Michael M. Ward · 2020 · Annals of the Rheumatic Diseases
  80. Ischemic Stroke in a Young Patient with Nephrotic Syndrome and Antiphospholipid Syndrome
    K K Neoh, Angelina Siing Ngi Tang, Irene Looi · 2020 · Case Reports in Nephrology
  81. Secondary Erosive Arthritis in a Young Lady – A Rare Manifestation of Primary Antiphospholipid Antibody Syndrome
    Sathish Muthu, Girinivasan Chellamuthu, Thiruvenkita Prasad Gopalsamy · 2021 · Journal of Orthopaedic Case Reports
  82. Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition
    Yoshihide Asano, Jun Asai, Takeshi Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe et al. · 2025 · The Journal of Dermatology
  83. Perspective on Renal Involvement in Antiphospholipid Syndrome: Implications for Diagnosis, Pathogenesis, and Treatment
    Ariela Hoxha, Dorella Del Prete, Irene Condonato · 2025 · Journal of Clinical Medicine
  84. Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome—A Single-Centre Cohort Study
    Natali Karandyszowska, Francesca Faustini, Hevgin Alagündüz, Jacob Widaeus, Felicia Carlens, Ann-Louise Jensen, Anna Oksanen, Maria Magnusson, Iva Gunnarsson, Elisabet Svenungsson et al. · 2025 · TH Open
  85. Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework
    Savino Sciascia, Silvia Aguillera, Diana Marinello · 2025 · Lupus Science & Medicine
  86. Are the 2023 ACR/EULAR classification criteria a step forward in the management of antiphospholipid syndrome? A literature-based and clinical practice appraisal
    Jaume Alijotas‐Reig, Joana Rita Marques-Soares, Enrique Esteve‐Valverde, Ariadna Anunciación-Llunell, Catalina Andrada, Monika Očková, Ariela Hoxha, Munther A. Khamashta, Yehuda Shoenfeld, Francesc Miró‐Mur · 2025 · Autoimmunity Reviews
  87. Management des systemischen Lupus erythematodes – inklusive sekundärem Antiphospholipidsyndrom, Kinderwunsch und Schwangerschaft
    Johanna Mücke, Hans‐Joachim Anders, Martin Aringer et al. · 2025 · Zeitschrift für Rheumatologie
  88. Development and validation of a EULAR disease activity score in antiphospholipid syndrome
    Maria G. Tektonidou, Ricard Cervera, Angela Tincani et al. · 2025 · Annals of the Rheumatic Diseases
  89. Predictors of long-term renal survival and mortality in patients with proliferative and membranous lupus nephritis
    Jung-Min Shin, Jiyoung Lee, Hye‐Soon Lee · 2026 · Lupus
  90. Relevance of systematic anti-nuclear antibodies testing after obstetrical complications
    Marie Koubi, Pascal M. Rossi, Robin Arcani · 2021 · Journal of Reproductive Immunology
  91. Anti-phosphatidyl-serine/prothrombin (aPS/PT) antibodies are superior predictors of LAC presence and APS diagnoses: A single center study
    Abdulrahman M. Saadalla, Vijayalakshmi Nandakumar · 2024 · Clinica Chimica Acta
  92. Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
    Ahmed H. Al-Jedai, Hajer Almudaiheem, Ibrahim Abdulrazag Al-Homood, Ibrahim A. AlMaghlouth, Sami M. Bahlas, Abdulaziz Mohammed Alolaiwi, Mohammad Ibrahim Ahmad Fatani, Maysa Tariq Eshmawi, Bedor A. Al-Omari, Khalidah Ahmed Owdetallah Alenzi et al. · 2024 · Current Rheumatology Reviews
  93. Primary antiphospholipid syndrome in the elderly: Four strokes and mechanical thrombectomies until the diagnosis - A case report
    Anatoli Anastasiadi, Chiara Bott, Daniel Kitterer · 2024 · Brain Circulation
  94. Proposal of a novel cardiovascular risk prediction score in lupus nephritis
    Adél Molnár, Márk Juha, Klaudia Bulajcsík · 2024 · Frontiers in Immunology
  95. Updates in diagnosis and treatment of pediatric antiphospholipid syndrome
    Lúcia Maria Arruda Campos, Paula Santana Marra, Clara Ribeiro Doria · 2024 · Current Rheumatology Reports
  96. Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome
    Anabel Franco‐Moreno, Aida Izquierdo-Martínez, Cristina de Ancos Aracil · 2024 · Drug Discoveries & Therapeutics
  97. Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV)
    Costantino Del Giudice, Guillaume Mahé, Frederic Thony, Stéphane Zuily, Gilles Goyault, A. Diard, Romaric Loffroy, J.‐P. Galanaud, Francine Thouveny, Isabelle Quéré et al. · 2024 · JMV-Journal de Médecine Vasculaire
  98. Placental lesions in patients with antiphospholipid antibody syndrome: experience of a single tertiary-care Italian reference center
    Valentina Canti, Rebecca DE LORENZO, Giulia Inguscio, Serena Girardelli, Mirko Pozzoni, Nazario Pio Tenace, Roberta Lucianò, Federica Pasi, Maria Teresa Castiglioni, Paolo Ivo Cavoretto et al. · 2024 · Frontiers in Lupus
  99. Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic
    C. DeFazio, Lara Horvath, Jennifer Morgan · 2024 · Lupus
  100. Primary versus secondary recurrent pregnancy losses: Clinical findings and live birth rate after comprehensive work‐up and personalized management
    Chiara Tersigni, Marianna Onori, Giuliana Beneduce, Fabio Sannino, Rita Franco, Andrea Busnelli, Chiara Granieri, Domenico Milardi, Alfredo Pontecorvi, Antonio Lanzone et al. · 2025 · Acta Obstetricia Et Gynecologica Scandinavica